U.S. markets closed
  • S&P 500

    4,170.42
    +45.76 (+1.11%)
     
  • Dow 30

    34,035.99
    +305.10 (+0.90%)
     
  • Nasdaq

    14,038.76
    +180.92 (+1.31%)
     
  • Russell 2000

    2,257.07
    +9.35 (+0.42%)
     
  • Crude Oil

    63.40
    -0.06 (-0.09%)
     
  • Gold

    1,764.40
    -2.40 (-0.14%)
     
  • Silver

    25.90
    -0.06 (-0.25%)
     
  • EUR/USD

    1.1976
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.5300
    -0.1080 (-6.59%)
     
  • GBP/USD

    1.3780
    -0.0004 (-0.03%)
     
  • USD/JPY

    108.7320
    +0.0160 (+0.01%)
     
  • BTC-USD

    63,350.98
    +573.50 (+0.91%)
     
  • CMC Crypto 200

    1,397.85
    +16.90 (+1.22%)
     
  • FTSE 100

    6,983.50
    +43.92 (+0.63%)
     
  • Nikkei 225

    29,642.69
    +21.70 (+0.07%)
     

Amgen To Present At The Cowen 41st Annual Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

THOUSAND OAKS, Calif., Feb. 24, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Cowen 41st Annual Virtual Healthcare Conference at 12:50 p.m. ET on Thursday, March 4, 2021. Murdo Gordon, executive vice president of Global Commercial Operations and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media)
Arvind Sood, 805-447-1060 (investors)

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)
Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-cowen-41st-annual-healthcare-conference-301234981.html

SOURCE Amgen